BioCardia announces data verification completion for Phase 3 CardiAMP HF study on heart failure treatment, with results due March 30, 2025. BioCardia, Inc. has completed source data verification and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback